Stock listing

NASDAQ:SVRA Savara, Inc. Stock

Home listing (NASDAQ) of Savara, Inc.

Follow Savara, Inc. into a list and get an email when it puts out news.

Share price · NASDAQ:SVRA

$4.76 USD -0.02 (-0.4%)

Close on Oct 14, 2026

Savara, Inc. logo
Ticker
NASDAQ:SVRA
Asset type
Stock
Exchange
NASDAQ
Currency
USD

What changed lately

Latest news

Savara to Present New Analysis from the IMPALA Clinical Trial and Deliver Encore Presentation of Long-Term Data on Molgramostim in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at CHEST 2026

Oct 12, 2026

Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP)

Aug 25, 2026

Savara Announces Encore Presentations of Results from the Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (APAP) at the European Respiratory Society (ERS) Congress 2026

Aug 24, 2026

Savara Reports Second Quarter 2026 Financial Results and Provides Business Update

Aug 11, 2026

Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041

Jul 30, 2026

Savara Announces Chief Financial and Administrative Officer Transition

Jun 8, 2026

Savara Announces Participation in the 2026 Jefferies Global Healthcare Conference

May 27, 2026

Savara Presented New Biomarker Data from the IMPALA-2 Phase 3 Clinical Trial of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP) at the American Thoracic Society (ATS) International Conference 2026

May 20, 2026

Savara Presented Long-Term Efficacy and Safety Data from the Ongoing IMPALA-2 Phase 3 Clinical Trial Open-Label (OL) Extension of Molgramostim Inhalation Solution (Molgramostim) in Autoimmune Pulmonary Alveolar Proteinosis (aPAP)

May 19, 2026

Savara Announces Participation in the H.C. Wainwright & Co. 4th Annual BioConnect Investor Conference

May 11, 2026

All Savara, Inc. news

Decks

Savara, Inc. on 6ix

News releases
35 in the last 12 months · 155 in all · newest Oct 12, 2026 · oldest 2019
Decks
43 decks · latest May 18, 2026

Where Savara, Inc. is listed

ListingExchangeCountryCurrency
NASDAQ:SVRA · Home listing · This pageNASDAQUnited StatesUSD
Lang & Schwarz:A2DQ2BLang & SchwarzGermanyEUR
LS Exchange:A2DQ2BLS ExchangeGermanyEUR
gettex:YB4PgettexGermanyEUR
Frankfurt:YB4PFrankfurtGermanyEUR
BOATS:SVRABOATSUnited StatesUSD
Tradegate:YB4PTradegateGermanyEUR
Dusseldorf:YB4PDusseldorfGermanyEUR
Munich:YB4PMunichGermanyEUR
Stuttgart:YB4PStuttgartGermanyEUR

Log in to ask 6ix AI your own questions about Savara, Inc.